White Papers
ISO 21973: A Leap Forward in Standardizing the Regenerative Medicine Supply Chain
The International Organization for Standardization (ISO) recently issued crucial guidance for the transportation of cells for therapeutic use (ISO 21973). It is imperative for...
News
Aruvant Chooses Lonza to Manufacture ARU-1801, a Potentially Curative Treatment for Sickle Cell Disease, for Pivotal Trial
Aruvant Sciences, a private company focused on developing gene therapies for rare diseases, and Lonza announced their agreement in support of ARU-1801, Aruvant’s one-time...
News
ViGeneron inks research pact with Daiichi Sankyo to evaluate vgAAV for novel ophthalmic gene therapy
ViGeneron GmbH, a gene therapy company, announced a research collaboration to utilize its novel engineered adeno-associated virus (vgAAV) vectors with Daiichi Sankyo Company, Limited,...
Drug Research
Novartis and GSK announce collaboration to support scientific research into genetic diversity in Africa
Novartis and GSK announced the launch of a collaboration to support high-quality scientific research investigating the link between genetic diversity across different regions in...
Clinical Trials
Grifols begins clinical trial of a new treatment that would provide immediate immunity against COVID-19
Grifols, a global leader in the development of therapies with plasma-derived proteins with a track record of more than 100 years dedicated to enhancing...
News
NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms
“NextPharma is an established and well-respected company, with extensive experience in oral and topical finished dosage forms. As such, it is the ideal buyer...
Clinical Trials
Intravacc announces completion of formulation and manufacturing process development of PRV-101 vaccine candidate for Provention Bio
Intravacc, a world leader in translational research and development of vaccines, announced that a candidate polyvalent inactivated coxsackievirus B (CVB) vaccine it developed and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read